54 results on '"Velayos A"'
Search Results
2. Brief Communication: The Contemporary Probability of Occult Colorectal Cancer in Patients with Colitis-Related Dysplasia undergoing Colectomy
3. Increased Risk of Hospitalization, Surgery, and Venous Thromboembolism Among Patients With Inflammatory Bowel Disease and Malnutrition in a Large, Community-Based Health Care System
4. Brief Communication: The Contemporary Probability of Occult Colorectal Cancer in Patients with Colitis-Related Dysplasia undergoing Colectomy
5. S0695 Appropriateness of Medical and Surgical Treatments in Patients With Chronic Inflammation of the Ileal Pouch: A RAND Panel Approach
6. S784 Factors Associated With the Development of Malnutrition Among Patients With Inflammatory Bowel Disease in a Large Community-Based Healthcare System
7. S783 Increased Risk of Hospitalization, Surgery and Venous Thromboembolism Among Patients With Inflammatory Bowel Disease and Malnutrition in a Large, Community-Based Healthcare System
8. S702 Evaluation of a Novel Pharmacy Program for Reducing Variation in Prescribing Biologics for Inflammatory Bowel Disease
9. S0695 Appropriateness of Medical and Surgical Treatments in Patients With Chronic Inflammation of the Ileal Pouch: A RAND Panel Approach
10. S783 Increased Risk of Hospitalization, Surgery and Venous Thromboembolism Among Patients With Inflammatory Bowel Disease and Malnutrition in a Large, Community-Based Healthcare System
11. S784 Factors Associated With the Development of Malnutrition Among Patients With Inflammatory Bowel Disease in a Large Community-Based Healthcare System
12. S702 Evaluation of a Novel Pharmacy Program for Reducing Variation in Prescribing Biologics for Inflammatory Bowel Disease
13. Cost Effectiveness of Ulcerative Colitis Surveillance in the Setting of 5-Aminosalicylates
14. Use of Azathioprine and 6MP in Postoperative Crohnʼs: Changing Natural History or Just Along for the Ride?
15. Utilizing Therapeutic Drug Monitoring of Biological Therapy in Inflammatory Bowel Disease
16. Risk Factors for Colorectal Neoplasia in Inflammatory Bowel Disease: A Nested Case–Control Study From Copenhagen County, Denmark and Olmsted County, Minnesota
17. Effect of 5-Aminosalicylate Use on Colorectal Cancer and Dysplasia Risk: A Systematic Review and Metaanalysis of Observational Studies
18. Low Rate of Microsatellite Instability in Young Patients with Adenomas: Reassessing the Bethesda Guidelines
19. 829 Appropriateness of Treatment Options in Mild to Moderate Ulcerative Colitis: A RAND Appropriateness Panel
20. Utilizing Therapeutic Drug Monitoring of Biological Therapy in Inflammatory Bowel Disease
21. Variation in IBD Prevalence by Race/Ethnicity Within an Integrated Healthcare Delivery System
22. Variation in IBD Prevalence by Race/Ethnicity Within an Integrated Healthcare Delivery System
23. Appropriateness of De-Escalation of Medical Therapy in Crohnʼs Disease Patients Who Are in Deep Remission: A RAND Panel Approach
24. Appropriateness of De-Escalation of Medical Therapy in Crohnʼs Disease Patients Who Are in Deep Remission: A RAND Panel Approach
25. In the Knick of Time: A Case of Bowel Perforation in Granulomatosis With Polyangiitis and the Use of Rituximab
26. In the Knick of Time: A Case of Bowel Perforation in Granulomatosis With Polyangiitis and the Use of Rituximab
27. Positioning Treatments for Ulcerative Colitis: A RAND Appropriateness Panel
28. Excellent Interobserver Agreement Between a Web-Based Self-Report Questionnaire and Medical Chart Review for the Management of Inflammatory Bowel Disease
29. Positioning Treatments for Ulcerative Colitis: A RAND Appropriateness Panel
30. Excellent Interobserver Agreement Between a Web-Based Self-Report Questionnaire and Medical Chart Review for the Management of Inflammatory Bowel Disease
31. Interpretation of Anti-TNF Drug Concentration and Antibody Levels in IBD: A Mobile App to Guide Management Based on Results From a RAND Appropriateness Panel
32. Heterotopic Gastric Mucosa (HGM) Mimicking Rectal Neoplasm on Colonoscopy
33. Interpretation of Anti-TNF Drug Concentration and Antibody Levels in IBD: A Mobile App to Guide Management Based on Results From a RAND Appropriateness Panel
34. Setting Priorities for Comparative Effectiveness Research in Inflammatory Bowel Disease: Results of an International Provider Survey, Expert RAND Panel, and Patient Focus Groups
35. Ustekinumab in Treatment of Crohnʼs Disease Patients with Refractory Disease: Case Series
36. Factors Influencing the Treatment of Inflammatory Bowel Disease in Patients with Cancer Recurrence: Pilot Study
37. Heterotopic Gastric Mucosa (HGM) Mimicking Rectal Neoplasm on Colonoscopy
38. Colorectal Cancer Screening and Surveillance in the Elderly Patient
39. Setting Priorities for Comparative Effectiveness Research in Inflammatory Bowel Disease: Results of an International Provider Survey, Expert RAND Panel, and Patient Focus Groups
40. Ustekinumab in Treatment of Crohnʼs Disease Patients with Refractory Disease: Case Series
41. The Appropriateness of Concomitant Immunomodulators with Anti-TNFα Agents for the Treatment of Crohnʼs Disease: An Evidence-Based Approach
42. Prognosis of Dysplasia in Ulcerative Colitis: A Community Cohort Study
43. Incidence of Colorectal Cancer in Inflammatory Bowel Disease
44. Prognosis of Dysplasia in Ulcerative Colitis: A Community Cohort Study
45. Gastroenterologists’ Practices and Attitudes Regarding Inflammatory Bowel Disease
46. Participation in Colonoscopic Cancer Surveillance among Patients with Ulcerative Colitis: Meeting Expectations?
47. Incidence of Colorectal Cancer in Inflammatory Bowel Disease
48. Participation in Colonoscopic Cancer Surveillance among Patients with Ulcerative Colitis: Meeting Expectations?
49. Gastroenterologists’ Practices and Attitudes Regarding Inflammatory Bowel Disease
50. EARLY PREDICTORS OF SIGNIFICANT LOWER INTESTINAL BLEEDING AND ADVERSE EVENTS: A PROSPECTIVE STUDY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.